MRNA compared with PFE: revenue, margins and what each company keeps, and the suppliers and customers both name

MRNAModerna, Inc.

Mkt capRevenueRevenue

PFEPfizer Inc

Mkt capRevenueRevenue

Compare

MRNAModerna, Inc.

PFEPfizer Inc

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Supply-chain overlap

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only MRNA 12

MRKMerckcustomer

VRTXVertex Pharmaceuticalscustomer

PSNLPersonalissupplier

ABUSArbutus Biopharmasupplier

8 more · MRNA chain ›

Shared 0

No shared counterparties.

Only PFE 34

MIRMMirum Pharmaceuticalscustomer

ICUIICU Medicalcustomer

BEAMBeam Therapeuticssupplier

ADPTAdaptive Biotechnologiessupplier

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

30 more · PFE chain ›

MRNAModerna, Inc.

255.58▼−4.99%

Mkt cap$108.8BRevenue$1.3BQ3 FY26Revenue$1.9BFY25

PFEPfizer Inc

29.25▲+0.07%

Regular sessionNov 10 '26

Mkt cap$166.6BRevenue$16.6BQ3 FY26Revenue$62.6BFY25

Compare

Regular sessionNov 10 '26

MRNAModerna, Inc.

PFEPfizer Inc

255.58▼−4.99%

Price

29.25▲+0.07%

$108.8B

Mkt cap

$166.6B

Q3 FY26$1.3B

Revenue

$16.6BQ3 FY26

FY25$1.9B

Revenue

$62.6BFY25

MRNA255.58▼−4.99%vsPFE29.25▲+0.07%Regular sessionNov 10 '26